SETBP1 and miR-4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Albano, Francesco ^a,b   Anelli, Luisa ^a   Zagaria, Antonella ^a   Coccaro, Nicoletta ^a   Casieri, Paola ^a   Minervini, Angela ^a   Specchia, Giorgina ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Intronic miRNA; Primary myelofibrosis progression; SETBP1 and miR 4319 dysregulation; T(12; 18)(p13; q12) translocation

Indexed keywords

BINDING PROTEIN; CYTARABINE; HYDROXYUREA; MICRORNA; MICRORNA 4319; SET BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANEMIA; ARTICLE; CANCER GROWTH; CASE REPORT; CYTOGENETICS; DISEASE COURSE; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; LEUKOCYTOSIS; MALE; MOLECULAR MECHANICS; MYELOID METAPLASIA; SPLENOMEGALY;

AGED; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; NUCLEAR PROTEINS; PRIMARY MYELOFIBROSIS; TRANSLOCATION, GENETIC;

EID: 84864568928     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-48     Document Type: Article

References (8)

1. Introduction and overview of the classification of the myeloid neoplasms. Vardiman JW, Brunning RD, Arber DA, Le Beau MM, Porwit A, Tefferi A, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon: International Agency for Research on Cancer, Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, 4 2008 18 30
2. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Guglielmelli P, Tozzi L, Pancrazzi A, Bogani C, Antonioli E, Ponziani V, Poli G, Zini R, Ferrari S, Manfredini R, Bosi A, Vannucchi AM, Exp Hematol 2007 35 1708 1718 17976522
3. MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia. Hussein K, Theophile K, Dralle W, Wiese B, Kreipe H, Bock O, Platelets 2009 20 391 400 10.1080/09537100903114537 19811223
4. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Girardot M, Pecquet C, Boukour S, Knoops L, Ferrant A, Vainchenker W, Giraudier S, Constantinescu SN, Blood 2010 116 437 445 10.1182/blood-2008-06-165985 20445018
5. Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects. Lutter D, Marr C, Krumsiek J, Lang EW, Theis FJ, BMC Genomics 2010 11 224 10.1186/1471-2164-11-224 20370903
6. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Cristábal I, Blanco FJ, Garcia-Orti L, Marcotegui N, Vicente C, Rifon J, Novo FJ, Bandres E, Calasanz MJ, Bernabeu C, Odero MD, Blood 2010 115 615 625 10.1182/blood-2009-06-227363 19965692
7. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Cristábal I, Garcia-Orti L, Cirauqui C, Alonso MM, Calasanz MJ, Odero MD, Leukemia 2011 25 606 614 10.1038/leu.2010.294 21233840
8. Structure and activity of putative intronic miRNA promoters. Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y, Davidson BL, RNA 2010 16 495 505 10.1261/rna.1731910 20075166